Advertisement

Attenuation of ALS progression during pregnancy—lessons to be learned or just a coincidence?

  • Mirea HancevicEmail author
  • Hrvoje Bilic
  • Barbara Sitas
  • Gordana Pavlisa
  • Fran Borovecki
  • Ivana Munitic
  • Ervina Bilic
Brief Communication

Abstract

ALS is the most frequent motor neuron disorder in adults with suggested complex relationship regarding gender. Studies investigating ALS and hormones have provided varying results. ALS onset during pregnancy is uncommon and pregnancy after the ALS symptom onset is even rarer. We present three patients with the onset of ALS symptoms before or during pregnancy and propose a putative disease modifying mechanism leading to attenuation of disease progression that we observed during the pregnancies.

Keywords

ALS Pregnancy Hormones Gender Immunomodulation FUS 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants for whom identifying information is included in this article.

References

  1. 1.
    del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60(5):813–819CrossRefGoogle Scholar
  2. 2.
    Manjaly, Z.R., Scott, K.M., Abhinav, K., Wijesekera, L., Ganesalingam, J., Goldstein, L.H., Janssen, A., Dougherty, A., Willey, E., Stanton, B.R., Turner, M.R., Ampong, M.-A., Sakel, M., Orrell, R.W., Howard, R., Shaw, C.E., Leigh, P.N., and Al-Chalabi, A., 2010. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler, 11 (5), 439–442Google Scholar
  3. 3.
    Blasco, H., Guennoc, A.-M., Veyrat-Durebex, C., Gordon, P.H., Andres, C.R., Camu, W., and Corcia, P., 2012. Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler, 13 (6), 585–588Google Scholar
  4. 4.
    Byrne S, Heverin M, Bede P, Elamin M, Hardiman O (2014) Fecundity in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 15(3–4):204–206CrossRefGoogle Scholar
  5. 5.
    Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071CrossRefGoogle Scholar
  6. 6.
    Martínez HR, Marioni SS, Escamilla Ocañas CE, Gonzalez Garza MT, Moreno-Cuevas JE (2014) Amyotrophic lateral sclerosis in pregnancy: clinical outcome during the post-partum period after stem cell transplantation into the frontal motor cortex. Cytotherapy 16(3):402–405CrossRefGoogle Scholar
  7. 7.
    Sarafov S, Doitchinova M, Karagiozova Z, Slancheva B, Dengler R, Petri S, Kollewe K (2009) Two consecutive pregnancies in early and late stage of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(5–6):483–486CrossRefGoogle Scholar
  8. 8.
    Jong S, Huisman M, Sutedja N, Kooi A, Visser M, Schelhaas J, Schouw Y, Veldink J, den Berg L (2013) Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J Neurol 260(2):507–512CrossRefGoogle Scholar
  9. 9.
    Rooney JPK, Visser AE, D’Ovidio F, Vermeulen R, Beghi E, Chio A, Veldink JH, Logroscino G, van den Berg LH, Hardiman O (2017) A case-control study of hormonal exposures as etiologic factors for ALS in women: euro-MOTOR. Neurology 89(12):1283–1290CrossRefGoogle Scholar
  10. 10.
    Nakamizo T, Urushitani M, Inoue R, Shinohara A, Sawada H, Honda K, Kihara T, Akaike A, Shimohama S (2000) Protection of cultured spinal motor neurons by estradiol. Neuroreport 11(16):3493–3497CrossRefGoogle Scholar
  11. 11.
    Robinson DP, Klein SL (2012) Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav 62(3):263–271CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Villa A, Vegeto E, Poletti A, Maggi A (2016) Estrogens, Neuroinflammation, and neurodegeneration. Endocr Rev 37(4):372–402CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Markle JG, Fish EN (2014) SeXX matters in immunity. Trends Immunol 35(3):97–104CrossRefGoogle Scholar
  14. 14.
    Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis Group. N Engl J Med 339(5):285–291CrossRefGoogle Scholar
  15. 15.
    Zhao W, Beers DR, Liao B, Henkel JS, Appel SH (2012) Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis 48(3):418–428CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, Thonhoff JR, Alsuliman AS, Shpall EJ, Rezvani K, Appel SH (2017) ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight 2(5):e89530CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Sar M, Stumpf WE (1977) Androgen concentration in motor neurons of cranial nerves and spinal cord. Science (New York, NY) 197(4298):77–79CrossRefGoogle Scholar
  18. 18.
    Waragai M, Yamada T, Moroo I (1993) [The distribution of androgen receptor like protein in the central nervous system of rat and human medulla and spinal cord–immunohistochemical study]. No To Shinkei 45(7):661–667Google Scholar
  19. 19.
    Male hypogonadism (2017) Springer Berlin Heidelberg, New York, NYGoogle Scholar
  20. 20.
    Zhang T, Wu Y-C, Mullane P, Ji YJ, Liu H, He L, Arora A, Hwang H-Y, Alessi AF, Niaki AG, Periz G, Guo L, Wang H, Elkayam E, Joshua-Tor L, Myong S, Kim JK, Shorter J, Ong S-E, Leung AKL, Wang J (2018) FUS regulates activity of microRNA-mediated gene silencing. Mol Cell 69(5):787–801.e8CrossRefGoogle Scholar
  21. 21.
    Yamaguchi A, Takanashi K (2016) FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription. Sci Rep 6(1)Google Scholar
  22. 22.
    Amato MP, Bertolotto A, Brunelli R, Cavalla P, Goretti B, Marrosu MG, Patti F, Pozzilli C, Provinciali L, Rizzo N, Strobelt N, Tedeschi G, Trojano M, Comi G (2017 Oct) Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci 38(10):1849–1858CrossRefGoogle Scholar
  23. 23.
    Bammann BL, Coulam CB, Jiang NS (1980) Total and free testosterone during pregnancy. Am J Obstet Gynecol 137(3):293–298CrossRefGoogle Scholar
  24. 24.
    Ysrraelit MC, Correale J (2019 Jan) Impact of sex hormones on immune function and multiple sclerosis development. Immunology 156(1):9–22CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Department of NeurologyClinical Hospital Centre ZagrebZagrebCroatia
  2. 2.Department of PulmonologyClinical Hospital Centre ZagrebZagrebCroatia
  3. 3.School of MedicineUniversity of ZagrebZagrebCroatia
  4. 4.Laboratory of Molecular Immunology, Department of BiotechnologyUniversity of RijekaRijekaCroatia

Personalised recommendations